Definitive Healthcare Corp. (DH)

Definitive Healthcare Stock Forecast

Stock Price Forecast

The 5 analysts that cover Definitive Healthcare stock have a consensus rating of "Hold" and an average price target of $3.08, which forecasts a 235.80% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $6.00.

Price Target: $3.08 (+235.80%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$1.00	$3.08	$3.00	$6.00
Change	+9.03%	+235.80%	+227.08%	+554.16%

* Price targets were last updated on Mar 30, 2026.

Analyst Ratings

The average analyst rating for Definitive Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	4	4	4	3	3	3
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	6	6	6	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Saket Kalia Barclays	Barclays	Sell Maintains $2.75 → $1	Sell	Maintains	$2.75 → $1	+9.03%	Mar 30, 2026
David Hynes Canaccord Genuity	Canaccord Genuity	Hold Maintains $4 → $3	Hold	Maintains	$4 → $3	+227.08%	Feb 27, 2026
Jeff Garro Stephens & Co.	Stephens & Co.	Hold Maintains $3 → $2	Hold	Maintains	$3 → $2	+118.05%	Feb 27, 2026
Saket Kalia Barclays	Barclays	Sell Maintains $3 → $2.75	Sell	Maintains	$3 → $2.75	+199.83%	Dec 9, 2025
David Hynes Canaccord Genuity	Canaccord Genuity	Hold Maintains $5 → $4	Hold	Maintains	$5 → $4	+336.11%	Nov 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

230.35M

Decreased by -4.63%

from 241.52M

Revenue Next Year

232.05M

Increased by 0.74%

from 230.35M

EPS This Year

0.17

from -1.30

EPS Next Year

0.19

Increased by 11.51%

from 0.17

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	166.15M	222.65M	251.42M	252.20M	241.52M	230.35M	232.05M
Revenue Growth	40.43%	34.00%	12.92%	0.31%	-4.23%	-4.63%	0.74%
EPS	-0.19	-0.07	-1.79	-3.54	-1.30	0.17	0.19
EPS Growth	-	-	-	-	-	-	11.51%
Forward PE	-	-	-	-	-	5.33	4.78
No. Analysts	-	-	-	-	-	15	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	237.0M	246.1M
Avg	230.4M	232.1M
Low	216.6M	214.6M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-1.9%	6.8%
Avg	-4.6%	0.7%
Low	-10.3%	-6.8%

EPS Forecast

EPS	2026	2027	2028
High	0.20	0.23
Avg	0.17	0.19
Low	0.16	0.15

EPS Growth

EPS Growth	2026	2027	2028
High	-	34.2%
Avg	-	11.5%
Low	-	-14.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.